SANDU PHARMACEUTICALS LTD. Share Price

₹ 35.70

-₹0.25 (-0.7%)
1D
Last updated 02 Nov, 2026, 12:43 IST
BSE: 524703
|
Pharmaceuticals

SANDU PHARMACEUTICALS LTD. Share Price Today

As of 2 Nov 2026, SANDU PHARMACEUTICALS LTD. share price is ₹35.70. The stock opened at ₹35.95, compared to its previous close of ₹35.95. During today's trading session, SANDU PHARMACEUTICALS LTD. share price moved in the range of ₹35.10 to ₹36.35, with an average price of ₹35.73 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.00 and a high of ₹50.00.

Share price over the last 1 day fell from 35.95 to 35.70, ranging between 35.10 and 36.35.

₹35.10
0.70% down today
₹36.35
1D LOW
1D HIGH

SANDU PHARMACEUTICALS LTD. Stock Insights

Latest Earning
Op Profit TrendUp by 4.35% YoY
Latest Earning
Net Profit TrendUp by 6.16% YoY
Latest Earning
Revenue TrendDown by 23.11% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 7.96 % in last 1 yr
Shareholding Pattern
DIIDII increased stake by 198.08%
SANDU PHARMACEUTICALS LTD. stock performance
Open₹35.95
High₹36.35
Low₹35.10
Prev. close₹35.95
SANDU PHARMACEUTICALS LTD. trading activity
Volume142
Average traded price₹35.44
Last traded time12:43:20 02 Nov
Last traded quantity1

Circuit
L
H
₹28.76
₹43.14
52-week
L
H
₹30.00
₹50.00
Mkt Cap Cr
34.73

P/E
30.43

P/B
1.41

ROA
3.65%
ROE
4.74%

ROCE
6.87%

Quick Ratio
1.01

EV/EBITDA
15.24

Based on fundamentals, this stock's

Performance: 4 out of 5, Good
Performance
Good
Sandu Pharma. outperforming most market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Sandu Pharma. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Sandu Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SANDU PHARMACEUTICALS LTD. Company Background

ISIN
INE751D01014
Sector Market Cap
₹ 34.73 Cr

Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.

SANDU PHARMACEUTICALS LTD. Financial Highlights

  • Revenue: SANDU PHARMACEUTICALS LTD. reported revenue of ₹67.36 crore in FY25 vs ₹67.70 crore in FY24. It showed a decrease of 0.50% on a yearly basis.
  • Operating Profit: SANDU PHARMACEUTICALS LTD. reported an operating profit of ₹2.16 crore in FY25 vs ₹2.07 crore in FY24. It showed an increase of 4.35% on a year-on-year basis.
  • Net Profit: SANDU PHARMACEUTICALS LTD. reported a net profit of ₹1.55 crore in FY25 vs ₹1.46 crore in FY24. It showed an increase of 6.16% on a yearly basis.

SANDU PHARMACEUTICALS LTD. Quarterly Result Highlights

  • SANDU PHARMACEUTICALS LTD. reported revenue of ₹14.14 crore in Mar 2025, compared with ₹18.39 crore in Dec 2024, representing a decrease of 23.11% on a quarter-on-quarter (QoQ) basis.
  • SANDU PHARMACEUTICALS LTD. reported an operating profit of ₹0.34 crore in Mar 2025, compared with ₹0.80 crore in Dec 2024, representing a decrease of 57.50% on a quarter-on-quarter (QoQ) basis.
  • SANDU PHARMACEUTICALS LTD. reported a profit of ₹0.33 crore in Mar 2025, compared with ₹0.56 crore in Dec 2024, reflecting a decrease of 41.07% on a QoQ basis.
  • The earnings per share (EPS) of SANDU PHARMACEUTICALS LTD. stood at ₹1.60 during Mar 2025.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
37.79%
FII
0.00%
Other DII
0.02%
Retail and other
62.20%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

SANDU PHARMACEUTICALS LTD. Investment Returns

1 day
+1.81%

1 week
+5.77%

1 month
-0.69%

1 year
-18.30%

3 years
-42.50%

5 years
-28.10%

SANDU PHARMACEUTICALS LTD. Share Price History

SANDU PHARMACEUTICALS LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹35.56 / ₹35.95
+1.81%
29 Oct 26
₹37.06 / ₹35.31
-4.13%
28 Oct 26
₹32.81 / ₹36.83
+6.35%
27 Oct 26
₹34.65 / ₹34.63
-0.20%
Show more

SANDU PHARMACEUTICALS LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Revenue₹67.19₹67.28₹65.35
Other Income₹0.17₹0.42₹0.33
Total Revenue₹67.36₹67.70₹65.68
Total Expenses₹65.20₹65.63₹63.46
Profit Before Tax₹2.16₹2.07₹2.22
Tax₹0.61₹0.61₹0.70
Profit After Tax₹1.55₹1.46₹1.52
EPS - Basic₹1.60₹1.51₹1.62
EPS - Diluted₹1.60₹1.51₹1.62

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Profit before tax₹2.16₹2.07₹2.22
Income before WC changes₹2.86₹2.48₹2.69
Change in Assets-₹2.13₹2.61-₹3.99
Change in Liabilities₹0.80-₹3.83₹2.21
Change in WC-₹1.32-₹1.22-₹1.77
Cash flow from Operations₹0.95₹0.76₹0.22
Cash flow from Investing-₹0.19-₹1.31₹0.54
Cash flow from Financing-₹0.46-₹0.72₹0.58
Total Cash Flow₹0.30-₹1.27₹1.34
Cash (Start of the year)₹1.00₹2.28₹0.94
Cash (End of the year)₹1.30₹1.00₹2.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Non-Current Assets₹29.42₹30.11₹28.62
Current Assets₹26.30₹22.30₹25.55
Total Assets₹55.72₹52.41₹54.17
Current Liabilities₹12.09₹10.64₹13.88
Net Current Asset₹14.21₹11.66₹11.66
Non-Current Liabilities₹1.62₹1.18₹1.04
Equity Capital₹42.02₹40.59₹39.24
Total Equity & Liabilities₹55.72₹52.41₹54.17

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹69.93₹67.19₹67.28₹65.35
Other Income₹0.44₹0.17₹0.42₹0.33
Total Revenue₹70.38₹67.36₹67.70₹65.68
Total Expenses₹67.72₹65.20₹65.63₹63.46
Profit Before Tax₹2.66₹2.16₹2.07₹2.22
Tax₹0.89₹0.61₹0.61₹0.70
Profit After Tax₹1.77₹1.55₹1.46₹1.52
EPS - Basic₹1.83₹1.60₹1.51₹1.62
EPS - Diluted₹1.83₹1.60₹1.51₹1.62

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2.66₹2.16₹2.07₹2.22
Income before WC changes₹3.65₹2.86₹2.48₹2.70
Change in Assets₹3.10-₹2.13₹2.61-₹3.99
Change in Liabilities₹0.12₹0.80-₹3.83₹2.21
Change in WC₹3.22-₹1.32-₹1.22-₹1.78
Cash flow from Operations₹6.12₹0.95₹0.76₹0.22
Cash flow from Investing-₹0.57-₹0.18-₹1.31₹0.53
Cash flow from Financing-₹0.94-₹0.46-₹0.72₹0.58
Total Cash Flow₹4.60₹0.31-₹1.27₹1.33
Cash (Start of the year)₹1.30₹1.00₹2.27₹0.94
Cash (End of the year)₹5.91₹1.30₹1.00₹2.27

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹30.55₹29.42₹30.12₹28.63
Current Assets₹25.32₹26.30₹22.30₹25.54
Total Assets₹55.87₹55.72₹52.42₹54.17
Current Liabilities₹10.42₹12.09₹10.64₹13.88
Net Current Asset₹14.90₹14.21₹11.66₹11.66
Non-Current Liabilities₹1.77₹1.62₹1.18₹1.04
Equity Capital₹43.67₹42.02₹40.60₹39.24
Total Equity & Liabilities₹55.87₹55.72₹52.42₹54.17
* All values are in INR Crore
SANDU PHARMACEUTICALS LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
235.2635.71199
10035.2536.234
235.1236.241
335.1136.2510
335.136.349
Total bid quantity110
Total ask quantity1,263
SANDU PHARMACEUTICALS LTD. technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
50.74
Neutral

ATR (14)
2.26
Neutral

STOCH(9,6)
72.79
Neutral

STOCH RSI (14)
81.49
Bearish

ADX(9)
26.35
Bearish

UO(9)
59.37
Neutral

ROC(12)
3.75
Bullish

WillR(14)
-27.21
Neutral
Period
Simple value
Exponential vaue

5D
35.48
35.5

10D
34.97
35.32

20D
35.54
35.56

50D
36.67
36.58

100D
38.56
37.52
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SANDU PHARMACEUTICALS LTD.
Pharmaceuticals
Add Stock
Add Another

SANDU PHARMACEUTICALS LTD. Returns Calculator

Ex-date: 04 Sep 2026

SANDU PHARMACEUTICALS LTD. Share Price FAQs












Please be aware that SANDU PHARMACEUTICALS LTD. stock prices are subject to continuous fluctuations due to various factors.